ClinicalTrials.govpublic full text
Open-label Comparison of 24hr Gastric pH on Days 1, 2, 7 With Once-daily Administration of Lavoltidine 40 mg.
gastroesophageal reflux disease, reflux, gastroesophageal, pharmacodynamics,, tolerance, h2 antagonist,, ah23844,, lavoltidine,, gastroesophageal reflux disease (gerd), pharmacokinetics,, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 893300
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.